Inhibrx Biosciences, Inc. INBX Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$140.06M-108% | $1.74B+819% | ||
| $2.48M+8.7% | $2.28M+91.8% | ||
| $11.14M-81.0% | $58.52M— | ||
| $2.44M— | —— | ||
| —— | $185K— | ||
| -$3.3M— | —— | ||
| -$4.36M-112% | $35.88M— | ||
| $0-100% | $3.7M— | ||
| -$1.6M-13.3% | -$1.41M— | ||
| -$20K+96.5% | -$566K— | ||
| -$129.79M+33.2% | -$194.41M— | ||
| —— | $2.6M— | ||
| —— | -$2.6M— | ||
| $1.61M— | —— | ||
| $101.45M— | —— | ||
| —— | -$125.33M— | ||
| $8.9M— | —— | ||
| —— | —— | ||
| $2.44M— | —— | ||
| —— | —— | ||
| -$1.6M-13.3% | -$1.41M— | ||
| -$20K+96.5% | -$566K— | ||
| -$1.4M+53.1% | -$2.98M— | ||
| $1.8M-5.0% | $1.9M+7.5% | ||
| —— | —— | ||
| $0-100% | $2B— | ||
| —— | —— | ||
| $125K— | $0— | ||
| -$1.6M-13.3% | -$1.41M— | ||
| $1.72M— | $0— | ||
| —— | —— | ||
| —— | $0— | ||
| $0— | —— | ||
| —— | —— | ||
| -$129.83M+34.1% | -$197.01M— | ||
| -$129.83M+34.1% | -$197.01M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Inhibrx Biosciences, Inc. generate?
- Inhibrx Biosciences, Inc. (INBX) generated -$131.9M in operating cash flow over the trailing twelve months.
- What is Inhibrx Biosciences, Inc.'s free cash flow?
- After $47.0K of capital expenditures, Inhibrx Biosciences, Inc.'s free cash flow was -$131.9M over the trailing twelve months, up 21.8% year over year.
- Where does Inhibrx Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
